OurCrowd portfolio company BioCatch was featured on Bloomberg Television’s “The Pulse.” In the interview, Benny Rosenbaum, Chief Executive Officer at BioCatch, talks with Elliott Gotkine about turning online fraud into art as they visualize the trails left behind by criminals on computers. BioCatch raised $3,334,500 from OurCrowd investors in February 2014. View the video below or play it on Bloomberg...
Read MoreOurCrowd portfolio company EdenShield was featured in The Huffington Post, a leading online news source, content aggregator and blog. EdenShield are the producers of a novel plant extract from the Israeli Judean Desert that makes crops odorless to pests, preventing multi-billion dollar crop damage. While traditional farmers may be slow to adopt EdenShield’s natural extracts, grown and extracted in Israel and then used on netting in the field or applied in the greenhouse, large grow operations for medical cannabis have been taking note. The team is currently trying their product in Israel and in Africa and are farming the natural substance (plant name is secret) in the northeast Negev Desert. In a kibbutz. They have recently expanded their production from 3 to 30 dunams and are anticipating $1 million USD in sales next year. EdenShield raised $712,000 from OurCrowd investors in 2014. Read more on The Huffington...
Read MoreOurCrowd portfolio company MedAware was featured in Globes, the leading Israeli financial daily. Medication errors greatly affect a vast number of people and institutions, harming an estimated 1.5 million Americans each year. Medaware seeks to provide better preventative services than other prescription reviewing systems. MedAware has developed an innovative software-based solution that combines the power of big data analytics and machine learning to save lives and reduce medical costs by combating prescription errors. MedAware Co-Founder and CEO Gidi Stein said, “Three years ago I came across a tragic case of a nine-year-old Israeli boy who died because his primary-care physician accidentally prescribed the wrong drug. The ease with which a little boy died because of a mistaken click of a button was horrifying to me as a physician and as a parent. We have founded MedAware in order to try and prevent such cases.” MedAware raised $1 million from GE Ventures and OurCrowd investors in 2014. Read more on...
Read More![[PRESS RELEASE] OurCrowd’s Portfolio Company ReWalk Launches IPO on NASDAQ](https://blog.gold.ocdvlp.com/wp-content/uploads/2017/07/press_release_image.jpg)
Jerusalem, Israel September 30, 2014: OurCrowd, the leading equity crowdfunding platform for accredited investors, announced today that its portfolio company ReWalk Robotics (RWLK) has completed its successful IPO on the NASDAQ. The company issued 3,450,000 million shares and expects to receive total estimated net proceeds from this offering of approximately $36.3 million after deducting estimated underwriting discounts and commissions and estimated offering expenses. Read more...
Read More
Jerusalem, Israel September 30, 2014: OurCrowd, the leading equity crowdfunding platform for accredited investors, announced today that its portfolio company ReWalk Robotics (RWLK) has completed its successful IPO on the NASDAQ. The company issued 3,450,000 million shares and expects to receive total estimated net proceeds from this offering of approximately $36.3 million after deducting estimated underwriting discounts and commissions and estimated offering expenses. Read more...
Read More
